Patients’ treatment limitations as predictive factor for mortality in COVID-19: results from hospitalized patients of a hotspot region for SARS-CoV-2 infections

Table 4 Predictors of mortality without taking into account treatment limitations

Predictor	b	SE	OR	95% CI		p-value
Sex (female vs. male)	− 0.37	0.30	0.69	0.38	1.17	0.190
Age	0.03	0.02	1.03	1.00	1.06	0.054
PAD	0.41	0.56	1.51	0.50	4.57	0.409
Cardiovascular disease	− 0.48	0.37	0.62	0.29	1.27	0.177
Obstructive airway disease	− 0.15	0.43	0.86	0.34	1.90	0.712
Malignant disease	− 0.06	0.42	0.94	0.39	2.05	0.875
Dementia	0.63	0.39	1.87	0.91	4.26	0.088
CCI	0.24	0.09	1.27	1.09	1.58	0.004
eGFR ≤ 55 (ml/min)	0.92	0.31	2.50	1.34	5.00	0.001
SpO₂ ≤ 93%	0.61	0.30	1.85	1.09	3.49	0.029
Neutrophils ≥ 5 (G/l)	0.63	0.31	1.88	1.01	3.49	0.039
CRP ≥ 7 (mg/dl)	1.61	0.33	4.88	2.94	10.59	0.001

For the definition of abbreviations see Tables 2, 3. The results shown are based on 439 patients having complete data for all of the predictors included
Bold p-values represent statistical significance (< 0.05)

ISSN: 1465-993X